Modern view on the pathogenesis and treatment principles of premenstrual syndrome


Cite item

Full Text

Abstract

The article presents the current data on etiology, pathogenesis, risk factors of premenstrual syndrome, and the basic principles of diagnosis and treatment of this pathological condition.

About the authors

V E Balan

ГБУЗ МО Московский областной научно-исследовательский институт акушерства и гинекологии

Email: balanmed@gmail.com
д-р мед. наук, проф., рук. научно-поликлинического отд-ния

L M Ilyina

ГБУЗ МО Московский областной научно-исследовательский институт акушерства и гинекологии

канд. мед. наук, мл. науч. сотр.

References

  1. Tschudin S, Bertea P.C, Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population - based sample. Arch Womens Ment Health 2010; 13 (6): 485–94.
  2. Baker L.J, O’Brien P.M. Premenstrual syndrome (PMS): a perimenopausal perspective. Maturitas 2012; 72 (2): 121–5.
  3. Birzniece V, Bäckström T, Johansson I.M et al. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res Rev 20064 51 (2): 212–39. Epub 2005 Dec 20.
  4. Matsumoto T, Asakura H, Hayashi T. Biopsychosocial aspects of premenstrual syndrome and premenstrual dysphoric disorder. Gynecol Endocrinol 2013; 29 (1): 67–73.
  5. Andrade C, Sandarsh S, Chethan K.B, Nagesh K.S. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010; 71 (12): 1565–75.
  6. Poiană C, Muşat M, Carsote M, Chiriţă C. Premenstrual dysphoric disorder: neuroendocrine interferences. Rev Med Chir Soc Med Nat Iasi 2009;113 (4): 996–1000.
  7. Dennerstein L, Lehert P, Heinemann K. Global epidemiological study of variation of premenstrual symptoms with age and sociodemographic factors. Menopause Int 2011; 17 (3): 96–101.
  8. Bertone-Johnson E.R, Hankinson S.E, Johnson S.R, Manson J.E. Timing of alcohol use and the incidence of premenstrual syndrome and probable premenstrual dysphoric disorder. J Womens Health 2009; 18 (12): 1945–53.
  9. Сметник В.П., Тумилович Л.Г. Неоперативная гинекология. Спб.: СОТИС, 1995. Т. I; с. 129–38.
  10. Кузнецова М.Н. Клиника, патогенез и лечение предменструального синдрома. Дис. ... д - ра мед наук. М., 1971.
  11. Mathew P.G, Dun E.C, Luo J.J. A cyclic pain: the pathophysiology and treatment of menstrual migraine. Obstet Gynecol Surv 2013; 68 (2): 130–40.
  12. Allais G, Gabellari I.C, Burzio C et al. Premenstrual syndrome and migraine. Neurol Sci 2012; 33 (Suppl. 1): S111–5.
  13. Halbreich U, Backstrom T, Eriksson E et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol 2007; 23 (3): 123–30.
  14. Mc Laren J.S, Morris E, Rymer J. Gonadotrophin receptor hormone analogues in combination with add - back therapy: an update. Menopause Int 2012; 18 (2): 68–72.
  15. Freeman E.W et al. An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception 2012; 85 (5): 437–45.
  16. Lopez L.M, Kaptein A.A, Helmerhorst F.M. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2012; 2.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).